SNDL (SNDL) Q2 FY26 earnings call

SNDL navigated a challenging Q2 FY26 marked by market headwinds in both liquor and cannabis, leading to revenue and gross profit declines. Despite these pressures, the company demonstrated financial discipline through accelerated share repurchases and maintained a strong cash position. A significant milestone was achieved with the Parallel restructuring, opening direct access to the US medical cannabis market and providing a platform for future growth and strategic optionality.